1 year return (CAGR)
-10.58%
ChemoMetec A/S Exchange (CO, DKK)
CHEMM.CO
706.00
+34.50 (+5.14%)
HealthcareMedical Devices
Loading...
3 year return (CAGR)
39.09%
5 year return (CAGR)
-5.82%
10 year return (CAGR)
34.37%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
12.12B
Price/Sales
12.04
Ent value
11.96B
Price/Book
16.70
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
105.96%
Trailing P/E
31.21
PEG
-
Forward P/E
43.32
EPS growth
17.97%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 670.00 |
| Daily high | 713.50 |
| Daily low | 661.50 |
| Daily Volume | 119K |
| All-time high | 1128.00 |
| 1y analyst estimate | 685.00 |
| Beta | 1.38 |
| EPS (TTM) | 22.32 |
| Dividend per share | 0.00 |
| Ex-div date | 10 Oct 2025 |
| Next earnings date | 5 May 2026 |
Downside potential
Loading...
Downside potential data
| CHEMM.CO | S&P500 | |
| Current price drop from All-time high | -37.41% | -5.62% |
| Highest price drop | -88.30% | -56.47% |
| Date of highest drop | 28 Dec 2012 | 9 Mar 2009 |
| Avg drop from high | -46.04% | -10.64% |
| Avg time to new high | 44 days | 12 days |
| Max time to new high | 1941 days | 1805 days |
News
ANNOUNCEMENT NO. 3276 November 2026 ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation No. 596/2014 concerning transactions in shares of ChemoMetec A/S carri...
November 6, 2026
ANNOUNCEMENT NO. 321 19 October 2026 ChemoMetec A/S will publish its financial results for the first quarter of the 2026/27 financial year on Thursday, November 5, 2026. In this connection, ChemoMetec...
October 19, 2026
ANNOUNCEMENT NO. 319 8 October 2026 The Annual General Meeting of ChemoMetec A/S was held on 8 October 2026 at 17:30 at Nordsjællands KonferenceCenter. At the Annual General Meeting, the Board of Dire...
October 8, 2026
ANNOUNCEMENT NO. 3175 October 2026 ChemoMetec maintained its positive momentum in the first quarter of the 2026/27 financial year, supported by higher-than-expected demand for our instruments, with th...
October 5, 2026
ANNOUNCEMENT NO. 3162 October 2026 ChemoMetec A/S has completed the share buyback programme announced in company announcement no. 309 dated 15 May 2026. The programme provided for the repurchase of up...
October 2, 2026
ChemoMetec AS (STU:CHY) posted record DKK511 million revenue with a 55% EBITDA margin, but management's conservative FY26/27 outlook and rising CapEx keep investors guessing.
September 19, 2026
16 September 2026ANNOUNCEMENT NO. 315 Major shareholder announcement - BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed Chemo...
September 16, 2026
ChemoMetec (CPSE:CHEMM) has just raised its revenue outlook for the 2026/27 financial year, guiding to DKK 570 million to 605 million. The update follows recent insider share transactions involving CF...
November 8, 2026
ANNOUNCEMENT NR. 3255 November 2026 Trading statement for Q1 2026/27 (1 July – 30 September 2026) Significant growth in both revenue and earnings Revenue was up by 28% in Q1 2026/27 to DKK 160.0 milli...
November 5, 2026
ChemoMetec reported first quarter revenue up 28% year on year and raised its 2026/27 revenue and EBITDA guidance on stronger NC-203 demand. The upgraded outlook, built on instrument demand and a highe...
November 4, 2026